Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 20 studies | 31% ± 13% | |
| astrocyte | 16 studies | 35% ± 16% | |
| fibroblast | 16 studies | 24% ± 9% | |
| oligodendrocyte | 12 studies | 33% ± 11% | |
| pericyte | 12 studies | 24% ± 9% | |
| microglial cell | 12 studies | 34% ± 11% | |
| macrophage | 11 studies | 29% ± 13% | |
| B cell | 10 studies | 24% ± 6% | |
| oligodendrocyte precursor cell | 10 studies | 39% ± 15% | |
| ciliated cell | 10 studies | 28% ± 10% | |
| GABAergic neuron | 9 studies | 46% ± 21% | |
| glutamatergic neuron | 9 studies | 47% ± 24% | |
| epithelial cell | 9 studies | 39% ± 20% | |
| basal cell | 9 studies | 34% ± 17% | |
| adipocyte | 9 studies | 30% ± 8% | |
| T cell | 8 studies | 22% ± 5% | |
| smooth muscle cell | 8 studies | 24% ± 6% | |
| endothelial cell of lymphatic vessel | 7 studies | 27% ± 10% | |
| neuron | 7 studies | 46% ± 21% | |
| type I pneumocyte | 7 studies | 26% ± 9% | |
| natural killer cell | 6 studies | 20% ± 3% | |
| interneuron | 6 studies | 49% ± 18% | |
| club cell | 6 studies | 30% ± 8% | |
| retina horizontal cell | 6 studies | 22% ± 5% | |
| retinal cone cell | 6 studies | 23% ± 4% | |
| dendritic cell | 6 studies | 23% ± 7% | |
| myeloid cell | 5 studies | 21% ± 3% | |
| cardiac muscle cell | 5 studies | 20% ± 4% | |
| respiratory goblet cell | 5 studies | 29% ± 10% | |
| monocyte | 5 studies | 24% ± 6% | |
| type II pneumocyte | 5 studies | 26% ± 8% | |
| granule cell | 4 studies | 29% ± 8% | |
| amacrine cell | 4 studies | 24% ± 8% | |
| retinal bipolar neuron | 4 studies | 19% ± 4% | |
| retinal pigment epithelial cell | 4 studies | 35% ± 18% | |
| CD4-positive, alpha-beta T cell | 4 studies | 16% ± 2% | |
| mesothelial cell | 4 studies | 29% ± 10% | |
| lymphocyte | 4 studies | 31% ± 10% | |
| Mueller cell | 4 studies | 23% ± 4% | |
| retinal rod cell | 4 studies | 27% ± 4% | |
| goblet cell | 4 studies | 35% ± 21% | |
| hematopoietic precursor cell | 3 studies | 25% ± 6% | |
| abnormal cell | 3 studies | 33% ± 21% | |
| GABAergic interneuron | 3 studies | 32% ± 6% | |
| glial cell | 3 studies | 30% ± 9% | |
| progenitor cell | 3 studies | 32% ± 5% | |
| retinal ganglion cell | 3 studies | 19% ± 2% | |
| brush cell | 3 studies | 27% ± 5% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| mononuclear phagocyte | 3 studies | 21% ± 0% | |
| GABAergic amacrine cell | 3 studies | 23% ± 4% | |
| ON-bipolar cell | 3 studies | 21% ± 4% | |
| glycinergic amacrine cell | 3 studies | 25% ± 6% | |
| rod bipolar cell | 3 studies | 23% ± 4% | |
| hepatocyte | 3 studies | 39% ± 16% | |
| CD8-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
| connective tissue cell | 3 studies | 26% ± 4% | |
| ependymal cell | 3 studies | 44% ± 16% | |
| enteroendocrine cell | 3 studies | 26% ± 8% | |
| leukocyte | 3 studies | 28% ± 9% | |
| myofibroblast cell | 3 studies | 31% ± 9% | |
| alveolar macrophage | 3 studies | 27% ± 8% | |
| chondrocyte | 3 studies | 23% ± 4% | |
| transit amplifying cell | 3 studies | 43% ± 30% | |
| mural cell | 3 studies | 31% ± 12% | |
| mucus secreting cell | 3 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 6551.57 | 21 / 21 | 100% | 54.76 | 504 / 504 |
| esophagus | 100% | 5554.47 | 1445 / 1445 | 100% | 66.56 | 183 / 183 |
| lung | 100% | 5277.63 | 578 / 578 | 100% | 52.50 | 1155 / 1155 |
| ovary | 100% | 7315.82 | 180 / 180 | 100% | 54.62 | 430 / 430 |
| breast | 100% | 5938.42 | 459 / 459 | 100% | 87.35 | 1116 / 1118 |
| intestine | 100% | 6035.79 | 966 / 966 | 100% | 53.03 | 526 / 527 |
| prostate | 100% | 6538.46 | 245 / 245 | 100% | 54.54 | 501 / 502 |
| uterus | 100% | 7159.10 | 170 / 170 | 100% | 59.27 | 458 / 459 |
| brain | 100% | 4215.45 | 2634 / 2642 | 100% | 53.86 | 705 / 705 |
| stomach | 100% | 4796.59 | 359 / 359 | 100% | 57.77 | 285 / 286 |
| thymus | 100% | 6313.36 | 653 / 653 | 99% | 48.95 | 601 / 605 |
| pancreas | 100% | 2866.52 | 327 / 328 | 99% | 40.50 | 176 / 178 |
| kidney | 100% | 4284.04 | 89 / 89 | 98% | 38.90 | 884 / 901 |
| adrenal gland | 100% | 5787.80 | 258 / 258 | 98% | 34.78 | 225 / 230 |
| skin | 100% | 6817.01 | 1809 / 1809 | 98% | 62.24 | 461 / 472 |
| liver | 100% | 2747.93 | 226 / 226 | 89% | 23.32 | 360 / 406 |
| adipose | 100% | 5545.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5541.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 36.98 | 29 / 29 |
| muscle | 100% | 4277.71 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 6584.11 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 54.88 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 21.12 | 1 / 1 |
| heart | 98% | 2954.82 | 842 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 96% | 39.78 | 77 / 80 |
| peripheral blood | 77% | 3463.27 | 711 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0044849 | Biological process | estrous cycle |
| GO_0019934 | Biological process | cGMP-mediated signaling |
| GO_0010468 | Biological process | regulation of gene expression |
| GO_0045773 | Biological process | positive regulation of axon extension |
| GO_0010976 | Biological process | positive regulation of neuron projection development |
| GO_0010629 | Biological process | negative regulation of gene expression |
| GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0050805 | Biological process | negative regulation of synaptic transmission |
| GO_0051402 | Biological process | neuron apoptotic process |
| GO_0001933 | Biological process | negative regulation of protein phosphorylation |
| GO_0030182 | Biological process | neuron differentiation |
| GO_0033484 | Biological process | intracellular nitric oxide homeostasis |
| GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
| GO_0009743 | Biological process | response to carbohydrate |
| GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
| GO_0051965 | Biological process | positive regulation of synapse assembly |
| GO_0007614 | Biological process | short-term memory |
| GO_0005615 | Cellular component | extracellular space |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0030425 | Cellular component | dendrite |
| GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
| GO_0030424 | Cellular component | axon |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0048487 | Molecular function | beta-tubulin binding |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0003682 | Molecular function | chromatin binding |
| GO_0042277 | Molecular function | peptide binding |
| GO_0008013 | Molecular function | beta-catenin binding |
| GO_0005507 | Molecular function | copper ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ADNP |
| Protein name | Activity dependent neuroprotector homeobox Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein) Activity-dependent neuroprotector homeobox |
| Synonyms | KIAA0784 ADNP1 |
| Description | FUNCTION: May be involved in transcriptional regulation. May mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation. Positively modulates WNT-beta-catenin/CTNN1B signaling, acting by regulating phosphorylation of, and thereby stabilizing, CTNNB1. May be required for neural induction and neuronal differentiation. May be involved in erythroid differentiation (By similarity). . |
| Accessions | A0A2R8YCL6 ENST00000645081.1 Q6DHZ8 ENST00000349014.8 ENST00000396029.8 Q9H2P0 ENST00000621696.5 ENST00000673732.1 A0A669KBJ7 ENST00000371602.9 A0A2R8Y6X0 ENST00000644386.1 ENST00000396032.8 |